Stanozolol

This product is a protein anabolic steroid drug, which has the effects of promoting protein synthesis, inhibiting protein anisotropy, lowering blood cholesterol and triglycerides, promoting calcium and phosphorus deposition, and alleviating bone marrow suppression, etc. It can enhance physical strength, increase appetite, and increase weight. This product has a strong protein anabolic effect, which is 30 times that of methyltestosterone, and its androgenic activity is about 25% of methyltestosterone.

Main ingredient: stanozolol. Its chemical name is: 17beta;-hydroxy-17alpha;-methylandrostanol[3,2-c]pyrazole. Molecular formula: C21H32N2O. Molecular weight: 328.50.

1. Prevention and treatment of hereditary angioedema; 2. Wasting diseases such as severe trauma, chronic infection, malnutrition, etc.

1 Common dosage for adults and adolescents to prevent and treat hereditary angioedema: Oral, start with 2 mg once, 3 times a day, females can take 2 mg once. Dosing should be individualized according to the patient's response. If the treatment effect is obvious, the dosage can be reduced every 1-3 months until the daily maintenance dose of 2 mg. However, the condition must be closely observed during the reduction process. For the treatment of chronic wasting diseases, postoperative weakness, and long-term trauma: Oral, 3 times a day, 2-4 mg once, females can reduce as appropriate. 2 Common dosage for children for hereditary angioedema. Under 6 years old, take 1 mg orally daily, only during an attack; 6-12 years old, take 2 mg orally daily, only during an attack.

1. Women: Long-term use may cause acne, hirsutism, clitoral hypertrophy, amenorrhea or menstrual disorders. 2. Men: Long-term use may cause acne, sperm reduction, and semen reduction. 3. Liver: Increased GOP and GTP, jaundice. 4. Digestive system: nausea, vomiting, indigestion, diarrhea. 5. Electrolytes: water and sodium retention, edema. 6. Skin: rash, facial flushing.

It is contraindicated for patients with severe liver disease, kidney disease, heart disease, hypertension, pregnant women and prostate cancer patients.

If you are using other medicines, please consult your physician or pharmacist before using this product.

Keep away from light and store in a sealed container.

Jiangxi Xinganjiang Pharmaceutical Co., Ltd.

• Founded in:

  2004-04-20

• Address:

  No. 36, Yunzhang Road, Jizhou District, Ji'an City, Jiangxi Province

• Tax NO.:

  91360800759975583T

• Registered Funds:

  70.86125 million yuan

• Website:

  Log in to view

• Email:

  Log in to view